Note: This section contains information in English only.
Fri, 07 Feb 2025 15:30:05 GMT
Source: Dukascopy Bank SA
Novo Nordisk faces investor pressure for more details on its next-gen obesity drug CagriSema, after unclear trial results caused a drop in its shares in December.
For further information regarding potential cooperation, please call us or make callback request.
To learn more about Dukascopy Bank Binary Options
/ Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Business Introducer and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.